Automated Oxygen Titration With the EMILY.AI Device During the Six-Minute Walk Test
Functional, Clinical, and Predictive Validation Study of the EMILY AI Device in Patients With Acute and Chronic Respiratory Failure: Exercise Substudy (Six-Minute Walk Test) in Ambulatory Patients
This study evaluates EMILY.AI, an investigational (non-CE-marked) smart oxygen valve that automatically adjusts the oxygen flow delivered to a patient.
Adults with chronic respiratory disease who need oxygen during exertion perform two six-minute walk tests on the same day, 30 minutes apart: one with oxygen adjusted automatically by EMILY.AI and one with a fixed oxygen flow delivered through the same device. The order is randomized and participants do not know which test uses automatic titration.
The study compares the time spent within the target saturation range, desaturation, oxygen use, walking distance, breathlessness and participant preference between the two tests. This substudy is part of clinical investigation FJD-EMILY-23-02, whose other substudies are registered in separate records.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
Background Patients with chronic respiratory disease often desaturate during exertion, and fixed-flow oxygen cannot follow the rapid changes in oxygen demand during walking and recovery. EMILY.AI combines a medical-grade oxygen valve with a rule-based algorithm that sets the oxygen flow.
Design Pilot, pragmatic, single-blind, randomized crossover study at Hospital Universitario Fundación Jiménez Díaz (Madrid, Spain). Each participant performs two supervised six-minute walk tests (6MWT) according to the American Thoracic Society guideline, separated by 30 minutes of rest: one with automatic titration by EMILY.AI and one with a fixed flow set by the physician, delivered through the same device so that the participant cannot tell them apart. The order of the two tests is randomized. Each test includes 6 minutes of walking and 2 minutes of standardized recovery.
Safety The medical team knows the device configuration and supervises the valve throughout each test.
Measurements SpO2, heart rate and respiratory rate are recorded with medical-grade pulse oximeters (Nonin, Masimo or Nihon Kohden models), together with distance walked, Borg dyspnoea score, oxygen delivered and participant-reported comfort, breathlessness and preference.
The protocol FJD-EMILY-23-02 also includes a substudy in the Respiratory Intermediate Care Unit and a substudy in a conventional hospital ward, registered separately.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Alba Naya Prieto, MD
- 전화번호: +34 915 50 48 00
- 이메일: alba.naya@fjd.es
연구 연락처 백업
- 이름: Sarah Beatrice Heili Frades, MD, PhD
- 전화번호: +34 915 50 48 00
- 이메일: SHeili@fjd.es
연구 장소
-
-
-
Madrid, 스페인, 28040
- 모병
- Hospital Universitario Fundación Jiménez Díaz
-
연락하다:
- Sarah Beatrice Heili Frades Zimmermann MD, PhD
- 전화번호: +34 915 50 48 00
- 이메일: SHeili@fjd.es
-
연락하다:
- Alba Naya Prieto, MD
- 전화번호: +34 915 50 48 00
- 이메일: alba.naya@fjd.es
-
수석 연구원:
- Sarah Beatrice Heili Frades Zimmermann, MD, PhD
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Aged 40 to 90 years with a chronic respiratory disease.
- Indication for exertional oxygen therapy, defined as SpO2 below 88% during a six-minute walk test and/or resting respiratory failure (PaO2 below 60 mmHg).
- Able to understand the study and sign informed consent.
Exclusion Criteria:
- Decompensated acute or chronic disease with severe organ involvement, such as cardiovascular disease.
- Musculoskeletal or neurological disease preventing stable and safe walking.
- Comorbidities or treatments that, by intensity or dose, limit performance of the tests or interpretation of the results (such as alcohol use, beta-blockers, or other neurological or psychiatric drugs).
- Walking limitation preventing the six-minute walk test, or cardiovascular or connective tissue disease limiting accurate transcutaneous pulse oximetry.
- Pregnancy or breastfeeding (women of childbearing potential require a negative pregnancy test at screening).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: EMILY.AI first, then fixed flow
First 6MWT with automatic titration by EMILY.AI; after 30 minutes of rest, second 6MWT with fixed-flow oxygen through the same device. |
Standard care: constant oxygen flow set by the physician, delivered through the EMILY.AI device in fixed mode so that the participant cannot distinguish it from automatic titration. Investigational smart oxygen valve with rule-based algorithm that adjusts oxygen flow every second from pulse-oximetry SpO2, heart rate and respiratory rate during walking and recovery.
다른 이름들:
|
|
실험적: Fixed flow first, then EMILY.AI
First 6MWT with fixed-flow oxygen through the device; after 30 minutes of rest, second 6MWT with automatic titration by EMILY.AI. |
Standard care: constant oxygen flow set by the physician, delivered through the EMILY.AI device in fixed mode so that the participant cannot distinguish it from automatic titration. Investigational smart oxygen valve with rule-based algorithm that adjusts oxygen flow every second from pulse-oximetry SpO2, heart rate and respiratory rate during walking and recovery.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Percentage of time with SpO2 within the target range
기간: Day 1
|
Percentage of test time (6 minutes of walking plus 2 minutes of recovery) with SpO2, measured by pulse oximetry, within the predefined target range (88-92%), without delivering oxygen while SpO2 is above the range. Compared between the test with automatic titration by EMILY.AI and the test with fixed flow. |
Day 1
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Percentage of test time with SpO2 below 88%
기간: Day 1
|
Percentage of test time (walking and recovery) with SpO2 below 88%, compared between conditions. |
Day 1
|
|
Number of desaturation episodes with SpO2 below 88%
기간: Day 1
|
Number of episodes per test in which SpO2 falls below 88%, compared between conditions. |
Day 1
|
|
Time to start of oxygen flow correction
기간: Day 1
|
Time in seconds from SpO2 leaving the target range (88-96%) to the start of an oxygen flow change, compared between conditions. |
Day 1
|
|
Time to return of SpO2 to the target range
기간: Day 1
|
Time in seconds from SpO2 leaving the target range (88-96%) to its return to the range, compared between conditions. |
Day 1
|
|
Percentage of test time with oxygen delivered while SpO2 is above 92%
기간: Day 1
|
Percentage of test time (walking and recovery) during which oxygen is delivered while SpO2 is above 92%, compared between conditions. |
Day 1
|
|
Number of episodes with oxygen delivered while SpO2 is above 92%
기간: Day 1
|
Number of episodes per test in which oxygen is delivered while SpO2 is above 92%, compared between conditions. |
Day 1
|
|
Total oxygen delivered
기간: Day 1
|
Total volume of oxygen delivered (litres) during each test including recovery, compared between conditions. |
Day 1
|
|
Mean oxygen flow
기간: Day 1
|
Mean oxygen flow (litres per minute) delivered during each test including recovery, compared between conditions. |
Day 1
|
|
Six-minute walk distance
기간: Day 1
|
Distance walked (metres), compared between conditions. |
Day 1
|
|
Change in dyspnoea measured with the modified Borg Dyspnoea Scale
기간: Day 1: before and immediately after each six-minute walk test
|
Change from the start to the end of each test in dyspnoea measured with the modified Borg Dyspnoea Scale, which ranges from 0 (no breathlessness at all) to 10 (maximal breathlessness). Higher scores mean a worse outcome. Compared between conditions. |
Day 1: before and immediately after each six-minute walk test
|
|
Maximum heart rate
기간: Day 1
|
Maximum heart rate (beats per minute) during each test, compared between conditions. |
Day 1
|
|
Maximum respiratory rate
기간: Day 1
|
Maximum respiratory rate (breaths per minute) during each test, compared between conditions. |
Day 1
|
|
Perceived difference in exercise capacity between the two tests
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Did you notice differences in your exercise capacity in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
|
Perceived difference in breathlessness between the two tests
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Did you notice differences in shortness of breath in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
|
Perceived difference in comfort of oxygen delivery between the two tests
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Did you notice differences in the comfort of oxygen delivery in either of the two tests?", and, if so, in which test. Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
|
Preference between the two oxygen delivery systems
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Do you prefer either of the two oxygen systems used in the tests?", and, if so, which one. Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
|
Preference for continuous automatic flow regulation at home
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Would you prefer your home oxygen system to regulate the oxygen flow continuously?". Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
|
Preference for telemonitored home oxygen
기간: Day 1: within 1 hour after the second six-minute walk test
|
Number of participants answering no, partially or yes to the question "Would you prefer your home oxygen system to be telemonitored by the medical team?". Categorical 3-option response, not a scored scale. |
Day 1: within 1 hour after the second six-minute walk test
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Sarah Beatrice Heili Frades, MD, PhD, MD, PhD, Hospital Universitario Fundación Jiménez Díaz
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- FJD-EMILY-23-02-TM6M
- FJD-EMILY-23-02 (기타 식별자: Aether Tech SL)
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .